A major Alzheimer’s disease-focused study is cautiously proceeding despite the COVID-19 pandemic. Sponsored by pharmaceutical company Eisai Inc., in collaboration with Biogen, the Alzheimer’s Clinical Trials Consortium, and the National Institute on Aging (NIA), this...